City

Birmingham (1)

New York (1)

Poitiers (1)

Salt Lake City (1)

Santa Monica (1)

Scottsdale (1)

Condition

Adenocarcinoma, Prostate (2)

Metastatic Castrate-resistant Prostate Cancer (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Takeda (1)

Tracon Pharmaceuticals Inc. (1)

Collaborator

Janssen Pharmaceutica N.V., Belgium (1)

Intervention

cyproterone acetate (1)

flutamide (1)

leuprorelin (1)

medroxyprogesterone acetate (1)

placebo (1)

trc253 (1)

venlafaxine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

adenocarcinoma, prostate

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Castrate-resistant Prostate Cancer, Adenocarcinoma, Prostate Trial in United States (TRC253)

Completed

Has Results

Metastatic Castrate-resistant Prostate Cancer
Adenocarcinoma, Prostate

TRC253

Birmingham, Alabama
+4 more

Mar 29, 2021

Adenocarcinoma, Prostate Trial in Poitiers (Cyproterone acetate, Medroxyprogesterone acetate, Venlafaxine)

Completed

Adenocarcinoma, Prostate

Cyproterone acetate
+5 more

Poitiers, France

Professor Jacques IRANI

Jul 29, 2015